Deep Track Capital, LP Rapt Therapeutics, Inc. Transaction History

Deep Track Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.28 - $25.46 $3.32 Million - $7.48 Million	293,966 Added 19.6%	1,793,966 $44.6 Million
Q3 2023 Nov 14, 2023	BUY	$16.34 - $24.66 $8.1 Million - $12.2 Million	495,439 Added 49.32%	1,500,000 $24.9 Million
Q2 2023 Aug 14, 2023	BUY	$16.06 - $21.61 $6.96 Million - $9.36 Million	433,328 Added 75.86%	1,004,561 $18.8 Million
Q1 2023 May 15, 2023	SELL	$17.19 - $30.8 $12.6 Million - $22.6 Million	-733,707 Reduced 56.23%	571,233 $10.5 Million
Q4 2022 Feb 14, 2023	BUY	$16.28 - $24.6 $21.2 Million - $32.1 Million	1,304,940 New	1,304,940 $25.8 Million

104

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $26.1M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.